These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9072429)

  • 1. Effect of chronic treatment with ME3221 on blood pressure and mortality in aged stroke-prone spontaneously hypertensive rats.
    Nagura J; Hui C; Yamamoto M; Yasuda S; Abe M; Hachisu M; Konno F
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S363-5. PubMed ID: 9072429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
    Nagura J; Yamamoto M; Hui C; Yasuda S; Hachisu M; Konno F
    Clin Exp Pharmacol Physiol; 1996 Mar; 23(3):229-35. PubMed ID: 8934613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats.
    Nagura J; Hui C; Yamamoto M; Yasuda S; Abe M; Hachisu M; Konno F
    Jpn J Pharmacol; 1996 May; 71(1):39-49. PubMed ID: 8791170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist.
    Nagura J; Yasuda S; Fujishima K; Yamamoto M; Hui C; Kawano K; Katano K; Ogino H; Hachisu M; Konno F
    Eur J Pharmacol; 1995 Feb; 274(1-3):201-11. PubMed ID: 7768273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
    Stier CT; Adler LA; Levine S; Chander PN
    J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal.
    Fornes P; Richer C; Vacher E; Bruneval P; Giudicelli JF
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):305-13. PubMed ID: 7692174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of an angiotensin II antagonist in stroke-prone spontaneously hypertensive rat.
    Yo Y; Moriguchi A; Higaki J; Nagano M; Nakano N; Kamide K; Yu H; Mikami H; Ogihara T
    Nephron; 1997; 76(4):466-71. PubMed ID: 9274845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats.
    Gohlke P; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1996 Sep; 28(3):397-402. PubMed ID: 8794823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
    Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H
    Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRH-594, a new angiotensin AT1 receptor antagonist, prevents end-organ damage in stroke-prone spontaneously hypertensive/Izm rats.
    Inada Y; Tazawa S; Murakami M; Akahane M
    Clin Exp Pharmacol Physiol; 2001 Mar; 28(3):206-11. PubMed ID: 11207677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of losartan on cerebral arteries in stroke-prone spontaneously hypertensive rats.
    Vacher E; Richer C; Giudicelli JF
    J Hypertens; 1996 Nov; 14(11):1341-8. PubMed ID: 8934363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
    Nishikawa K
    J Hum Hypertens; 1998 May; 12(5):301-9. PubMed ID: 9655651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoregulation of total and zonal glomerular filtration rate in spontaneously hypertensive rats during antihypertensive therapy.
    Wang X; Aukland K; Iversen BM
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):833-41. PubMed ID: 8961082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
    Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
    J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 2nd communication: valsartan prevents end-organ damage in spontaneously hypertensive stroke-prone rats during 1-year treatment.
    Kometani M; Hayashi N; Yamamoto S; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):613-9. PubMed ID: 9205774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats.
    Blezer EL; Nicolay K; Koomans HA; Joles JA
    Am J Hypertens; 2001 Jan; 14(1):54-61. PubMed ID: 11206680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
    Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
    J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel angiotensin II-receptor antagonist, 606A, induces regression of cardiac hypertrophy, augments endothelium-dependent relaxation and improves renal function in stroke-prone spontaneously hypertensive rats.
    Hashimoto Y; Kurosawa Y; Minami K; Fushimi K; Narita H
    Jpn J Pharmacol; 1998 Feb; 76(2):185-92. PubMed ID: 9541281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.